Present status and future orientation of rivaroxaban application in patients with nonvulvular atrial fibrillation

被引：0
|
作者：
Huang, Sui [1 ]
Tang, Liang [1 ]
Hu, Yu [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan 430022, Hubei, Peoples R China
来源：
THROMBOSIS RESEARCH | 2017年 / 156卷
关键词：
STROKE PREVENTION; ANTITHROMBOTIC THERAPY; WARFARIN; XANTUS; POPULATION;
D O I：
10.1016/j.thromres.2017.05.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：191 / 192
页数：2
相关论文
共 50 条
  • [21] Ablation of Paroxysmal Atrial Fibrillation: between Present and Future
    Robles, Antonio Gianluca
    Palama, Zefferino
    Scara, Antonio
    Borrelli, Alessio
    Gianfrancesco, Domenico
    Bartolomucci, Francesco
    Nesti, Martina
    Cavarretta, Elena
    De Luca, Gabriele De Masi
    Romano, Silvio
    Sciarra, Luigi
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (04)
  • [22] Application Value and Safety Analysis of Warfarin, Rivaroxaban, and Dabigatran Ester in Elderly Patients With Atrial Fibrillation
    Chen, Cheng
    Tian, Qing
    Cheng, Chong
    Ji, Xixin
    Feng, Mengyun
    Tan, Huiqun
    Zhou, Qian
    CLINICAL CARDIOLOGY, 2024, 47 (09)
  • [23] Concomitant Rivaroxaban and Dronedarone Administration in Patients With Nonvalvular Atrial Fibrillation
    Escobar, Carlos
    Arceluz, Martin
    Montes de Oca, Rosa
    Mori, Ricardo
    Luis Lopez-Sendon, Jose
    Luis Merino, Jose
    REVISTA ESPANOLA DE CARDIOLOGIA, 2017, 70 (02): : 121 - 122
  • [24] Effectiveness and Safety of Apixaban Versus Rivaroxaban for Patients With Atrial Fibrillation
    不详
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (07) : 463 - 473
  • [25] Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation
    Rillig, Andreas
    Lin, Tina
    Plesman, Joaquina
    Heeger, Christian-H.
    Lemes, Christine
    Metzner, Andreas
    Mathew, Shibu
    Wissner, Erik
    Wohlmuth, Peter
    Ouyang, Feifan
    Kuck, Karl-Heinz
    Tilz, Roland Richard
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (02) : 147 - 153
  • [26] Effects of rivaroxaban and dabigatran on global hemostasis in patients with atrial fibrillation
    Petkovic, Anica
    Al-Khalili, Faris
    Antovic, Aleksandra
    Ammar, Majeed
    Pruner, Iva
    Vranic, Aleksandra
    Soutari, Nida
    Zdravkovic, Nebojsa
    Malmstrom, Rickard E.
    Jakovljevic, Vladimir
    Antovic, Jovan P.
    BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (04) : 243 - 252
  • [27] Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation
    Providencia, Rui
    Marijon, Eloi
    Albenque, Jean-Paul
    Combes, Stephane
    Combes, Nicolas
    Jourda, Francois
    Hireche, Hassiba
    Morais, Joao
    Boveda, Serge
    EUROPACE, 2014, 16 (08): : 1137 - 1144
  • [28] Combination of Rivaroxaban and Amiodarone Increases Bleeding in Patients With Atrial Fibrillation
    Wang, Zi
    Li, Xiaoyu
    Zou, Ye
    Li, Xiaoye
    Lv, Qianzhou
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (08) : 761 - 770
  • [29] Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence
    Martinez-Rubio, Antoni
    Andrei Dan, George
    Carlos Kaski, Juan
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (08) : 933 - 947
  • [30] The Role of Rivaroxaban in a Comprehensive Protection Strategy for Patients with Atrial Fibrillation
    Zolotovskaya, I. A.
    Sabanova, V. D.
    Davydkin, I. L.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2021, 17 (02) : 294 - 302
12345